Hemodialysis graft flow surveillance with prompt corrective interventions improves access long-term patency

D Maoz1, R Reinitz, U Rimon

  • 1Department of Vascular Surgery, Sackler Faculty of Medicine, Sheba Medical Center, Tel Hashomer, Tel Aviv University, Tel Aviv, Israel.

Clinical Nephrology
|February 11, 2009
PubMed

Insights

Maintaining hemodialysis arteriovenous graft (AVG) patency requires vigilant flow surveillance and timely interventions. Key risk factors for graft thrombosis include low ejection fraction and early interventions.

Area of Science:

  • Vascular Surgery
  • Nephrology
  • Cardiovascular Physiology

Background:

  • Arteriovenous graft (AVG) patency is crucial for effective hemodialysis.
  • Favorable flow characteristics are essential for maintaining AVG patency.
  • Hemodynamic and humoral factors influence AVG longevity.

Purpose of the Study:

  • To investigate the impact of stringent flow surveillance and prompt corrective interventions on long-term AVG patency.
  • To identify hemodynamic and humoral risk factors associated with AVG failure.
  • To analyze the effectiveness of early intervention strategies.

Main Methods:

  • Monthly flow surveillance of 92 chronic hemodialysis patients with AVG over 29 months.
  • Diagnosis of failing grafts based on reduced flow, patient history, and hemodynamic parameters.
  • Angiography and corrective interventions (endovascular/surgical angioplasty) for identified stenotic lesions.

Main Results:

  • Stenotic lesions were found in 94.5% of grafts requiring intervention.
  • Low ejection fraction, early intervention, and low baseline flow significantly reduced intervention-free interval (p < 0.05).
  • Mean AVG flow threshold before intervention was 463 ± 154 ml/min (45 ± 12% reduction); primary patency at 24 months was 35% (secondary 88%).

Conclusions:

  • A stringent flow surveillance policy with prompt intervention effectively maintains long-term AVG patency.
  • Patients with decreased ejection fraction, early post-operative intervention, and low baseline AVG flow are at higher risk of graft thrombosis.
  • Early detection and management of flow reduction are critical for preserving AVG function.
Abstract

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...